US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Repros Therapeutics Inc. (MM) (RPRXD)
Repros Therapeutics Inc. (MM) (RPRXD) ニュース

RPRXD

Repros Therapeutics Inc. (MM) (RPRXD)

Repros Therapeutics Inc. (MM)

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:RPRXD

1

日付	受信時刻	ニュースソース	見出し	コード	企業名
2010/11/11	02 : 27	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:RPRXD	Repros Therapeutics Inc. (MM)
2010/11/10	03 : 29	Business Wire	Repros® Therapeutics Reports Outcome of Type B Meeting with FDA Regarding Androxal® in the Treatment of Secondary Hypogonadism	NASDAQ:RPRXD	Repros Therapeutics Inc. (MM)
2010/11/02	01 : 27	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:RPRXD	Repros Therapeutics Inc. (MM)
2010/10/30	06 : 20	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:RPRXD	Repros Therapeutics Inc. (MM)
2010/10/30	06 : 20	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:RPRXD	Repros Therapeutics Inc. (MM)
2010/10/30	06 : 04	Business Wire	Repros® Has Regained Compliance with Nasdaq Continued Listing Requirements	NASDAQ:RPRXD	Repros Therapeutics Inc. (MM)
2010/10/26	02 : 05	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:RPRXD	Repros Therapeutics Inc. (MM)
2010/10/25	23 : 36	Business Wire	Repros® Therapeutics Begins Randomization of Subjects in Androxal® Type II Diabetes Phase II Trial	NASDAQ:RPRXD	Repros Therapeutics Inc. (MM)
2010/10/16	06 : 39	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:RPRXD	Repros Therapeutics Inc. (MM)
2010/10/15	23 : 53	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:RPRXD	Repros Therapeutics Inc. (MM)

Showing the most relevant articles for your search:NASDAQ:RPRXD

1

Better World Acquisition

BNP Paribas Issuance

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約